HIV-1 infection and AIDS: Consequences for the central nervous system

Cell Death and Differentiation

Volumn 12, Issue , 2005, Pages 878-892

  Kaul, M ^a   Zheng, J ^b   Okamoto, S ^a   Gendelman, H E ^b   Lipton, S A ^a  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Central nervous system; Hiv 1; Immune activation; Inflammation; Macrophages microglia; NeuroAids; Neurodegeneration; Neurotoxicity; Pharmacology

Indexed keywords

ANTIRETROVIRUS AGENT; AUTACOID; CASPASE INHIBITOR; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CXCR4; DIDANOSINE; ERYTHROPOIETIN; GLUTAMATE RECEPTOR; MEMANTINE; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NIMODIPINE; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RANTES; SELEGILINE; SOMATOMEDIN C; STAVUDINE; STROMAL CELL DERIVED FACTOR 1; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNINDEXED DRUG; VALPROIC ACID; VASCULAR CELL ADHESION MOLECULE 1; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIOXIDANT ACTIVITY; APOPTOSIS; BEHAVIOR DISORDER; CELL DEATH; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL TRIAL; DEMENTIA; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; DRUG POTENTIATION; DRUG SAFETY; DRUG TARGETING; EXCITOTOXICITY; GLIA CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; MACROPHAGE; MOTOR DYSFUNCTION; NERVE DEGENERATION; NEURAL STEM CELL; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TREATMENT FAILURE; VIRUS LOAD; VIRUS PATHOGENESIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS DEMENTIA COMPLEX; ANIMALS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BRAIN; CHEMOKINES; FORECASTING; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MEMBRANE GLYCOPROTEINS; MICROGLIA; NERVE DEGENERATION; NEURONS; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION; STEM CELLS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 22744455058     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401623     Document Type: Review

References (198)

1. Piot P, Bartos M, Ghys PD, Walker N and Schwartlander B (2001) The global impact of HIV/AIDS. Nature 410: 968-973
2. McArthur JC (1987) Neurologic manifestations of AIDS. Medicine (Baltimore) 66: 407-437
3. McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NM, McArthur JH, Selnes OA and Jacobson LP (1993) Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43: 2245-2252
4. Kaul M, Garden GA and Lipton SA (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410: 988-994
5. Power C, Gill MJ and Johnson RT (2002) Progress in clinical neurosciences: the neuropathogenesis of HIV infection: host-virus interaction and the impact of therapy. Can. J. Neurol. Sci. 29: 19-32
6. Gendelman HE, Grant I, Lipton SA, Everall I and Swindells S (2005) The Neurology of AIDS 2nd edn (London: Oxford University Press)
7. Ellis RJ, Deutsch R, Heaton RK, Marcotte TD, McCutchan JA, Nelson JA, Abramson I, Thal LJ, Atkinson JH, Wallace MR and Grant I (1997) Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch. Neurol. 54: 416-424
8. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA and Fauci AS (1986) Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233: 1089-1093
9. Gartner S (2000) HIV infection and dementia. Science 287: 602-604
10. Persidsky Y, Zheng J, Miller D and Gendelman HE (2001) Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. J. Leukoc. Biol. 68: 413-422
11. Budka H, Costanzi G, Cristina S, Lechi A, Parravicini C, Trabattoni R and Vago L (1987) Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta. Neuropathol. (Berl.) 75: 185-198
12. Eilbott DJ, Peress N, Burger H, LaNeve D, Orenstein J, Gendelman HE, Seidman R and Weiser B (1989) Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: expression and replication in macrophages. Proc. Natl. Acad. Sci. USA 86: 3337-3341
13. Giulian D, Vaca K and Noonan CA (1990) Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250: 1593-1596
14. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, Keane RW, Resnick L, Mizrachi Y, Volsky DJ, Epstein L and Gendelman HE (1992) Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176: 1703-1718
15. Lipton SA and Gendelman HE (1995) Seminars in Medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 332: 934-940
16. Turchan J, Sacktor N, Wojna V, Conant K and Nath A (2003) Neuroprotective therapy for HIV dementia. Curr. HIV Res. 1: 373-383
17. Kaul M and Lipton SA (2004) Signaling pathways to neuronal damage and apoptosis in human immunodeficiency virus type 1-associated dementia: chemokine receptors, excitotoxicity, and beyond. J. Neurovirol. 10 (Suppl. 1): 97-101
18. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B and McArthur JC (2001) HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 56: 257-260
19. Dore GJ, Hoy JF, Mallal SA, Li Y, Mijch AM, French MA, Cooper DA and Kaldor JM (1997) Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: the Australian AIDS cohort. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 16: 39-43
20. Ferrando S, van Gorp W, McElhiney M, Goggin K, Sewell M and Rabkin J (1998) Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. AIDS 12: F65-F70
21. Gendelman HE, Zheng J, Coulter CL, Ghorpade A, Che M, Thylin M, Rubocki R, Persidsky Y, Hahn F, Reinhard Jr. J and Swindells S (1998) Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J. Infect. Dis. 178: 1000-1007
22. Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA and Brew BJ (1999) Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 13: 1249-1253
23. Major EO, Rausch D, Marra C and Clifford D (2000) HIV-associated dementia. Science 288: 440-442
24. Enting RH, Hoetelmans RM, Lange JM, Burger DM, Beijnen JH and Portegies P (1998) Antiretroviral drugs and the central nervous system. AIDS 12: 1941-1955
25. Cunningham PH, Smith DG, Satchell C, Cooper DA and Brew B (2000) Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid. AIDS 14: 1949-1954
26. Lipton SA (1997) Treating AIDS dementia [letter; comment]. Science 276: 1629-1630
27. Clifford DB (2000) Human immunodeficiency virus-associated dementia. Arch. Neurol. 57: 321-324
28. McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M and Lanier ER (1997) Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann. Neurol. 42: 689-698
29. Wiley CA, Soontornniyomkij V, Radhakrishnan L, Masliah E, Mellors J, Hermann SA, Dailey P and Achim CL (1998) Distribution of brain HIV load in AIDS. Brain Pathol. 8: 277-284
30. Nottet HS, Persidsky Y, Sasseville VG, Nukuna AN, Bock P, Zhai QH, Sharer LR, McComb RD, Swindells S, Soderland C and Gendelman HE (1996) Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J. Immunol. 156: 1284-1295
31. Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, Bock P, Gendelman HE and Fiala M (1997) A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J. Immunol. 158: 3499-3510
32. Asensio VC and Campbell IL (1999) Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci. 22: 504-512
33. Gonzalez E, Rovin BH, Sen L, Cooke G, Dhanda R, Mummidi S, Kulkarni H, Bamshad MJ, Telles V, Anderson SA, Walter EA, Stephan KT, Deucher M, Mangano A, Bologna R, Ahuja SS, Dolan MJ and Ahuja SK (2002) HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc. Natl. Acad. Sci. USA 99: 13795-13800
34. Prospero-Garcia O, Gold LH, Fox HS, Polis I, Koob GF, Bloom FE and Henriksen SJ (1996) Microglia-passaged simian immunodeficiency virus induces neurophysiological abnormalities in monkeys. Proc. Natl. Acad. Sci. USA 93: 14158-14163
35. Kalams SA and Walker BD (1995) Cytotoxic T lymphocytes and HIV-1 related neurologic disorders. Curr. Top Microbiol. Immunol. 202: 79-88
36. Mennicken F, Maki R, de Souza EB and Quirion R (1999) Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol. Sci. 20: 73-78
37. Zhao ML, Si Q and Lee SC (2004) IL-16 expression in lymphocytes and microglia in HIV-1 encephalitis. Neuropathol. Appl. Neurobiol. 30: 233-242
38. Sasseville VG, Newman W, Brodie SJ, Hesterberg P, Pauley D and Ringler DJ (1994) Monocyte adhesion to endothelium in simian immunodeficiency virus-induced AIDS encephalitis is mediated by vascular cell adhesion molecule-1/alpha 4 beta 1 integrin interactions. Am. J. Pathol. 144: 27-40
39. Fiala M, Looney DJ, Stins M, Way DD, Zhang L, Gan X, Chiappelli F, Schweitzer ES, Shapshak P, Weinand M, Graves MC, Witte M and Kim KS (1997) TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol. Med. 3: 553-564
40. Marshall DC, Wyss-Coray T and Abraham CR (1998) Induction of matrix metalloproteinase-2 in human immunodeficiency virus-1 glycoprotein 120 transgenic mouse brains. Neurosci. Lett. 254: 97-100
41. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A and Schall TJ (1997) A new class of membrane-bound chemokine with a CX3C motif. Nature 385: 640-644
42. Power C, McArthur JC, Nath A, Wehrly K, Mayne M, Nishio J, Langelier T, Johnson RT and Chesebro B (1998) Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J. Virol. 72: 9045-9053
43. Budka H (1991) Neuropathology of human immunodeficiency virus infection. Brain Pathol. 1: 163-175
44. Glass JD, Fedor H, Wesselingh SL and McArthur JC (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38: 755-762
45. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH and Grant I (1997) Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC group. The HIV Neurobehavioral Research Center. Ann. Neurol. 42: 963-972
46. Wesselingh SL, Takahashi K, Glass JD, McArthur JC, Griffin JW and Griffin DE (1997) Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/ polymerase chain reaction in situ hybridization and immunohistochemistry. J. Neuroimmunol. 74: 1-8
47. Giulian D, Yu J, Li X, Tom D, Li J, Wendt E, Lin SN, Schwarcz R and Noonan C (1996) Study of receptor-mediated neurotoxins released by HIV-1 infected mononuclear phagocytes found in human brain. J. Neurosci. 16: 3139-3153
48. Heyes MP, Brew BJ, Martin A, Price RW, Salazar AM, Sidtis JJ, Yergey JA, Mouradian MM, Sadler AE, Keilp J, Rubinow D and Markey SP (1991) Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29: 202-209
49. Jiang ZG, Piggee C, Heyes MP, Murphy C, Quearry B, Bauer M, Zheng J, Gendelman HE and Markey SP (2001) Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages. J. Neuroimmunol. 117: 97-107
50. Everall IP, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, Grant I, Mallory M and Masliah E (1999) Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC group. HIV Neurobehavioral Research Center. Brain Pathol. 9: 209-217
51. Fox L, Alford M, Achim C, Mallory M and Masliah E (1997) Neurodegeneration of somatostatin-immunoreactive neurons in HIV encephalitis. J. Neuropathol. Exp. Neurol. 56: 360-368
52. Masliah E, Ge N, Achim CL, Hansen LA and Wiley CA (1992) Selective neuronal vulnerability in HIV encephalitis. J. Neuropathol. Exp. Neurol. 51: 585-593
53. Adle-Biassette H, Levy Y, Colombel M, Poron F, Natchev S, Keohane C and Gray F (1995) Neuronal apoptosis in HIV infection in adults. Neuropathol. Appl. Neurobiol. 21: 218-227
54. Gelbard HA, James HJ, Sharer LR, Perry SW, Saito Y, Kazee AM, Blumberg BM and Epstein LG (1995) Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol. Appl. Neurobiol. 21: 208-217
55. Petito CK and Roberts B (1995) Evidence of apoptotic cell death in HIV encephalitis. Am. J. Pathol. 146: 1121-1130
56. Adle-Biassette H, Chretien F, Wingertsmann L, Hery C, Ereau T, Scaravilli F, Tardieu M and Gray F (1999) Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol. Appl. Neurobiol. 25: 123-133
57. Giulian D, Wendt E, Vaca K and Noonan CA (1993) The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc. Natl. Acad. Sci. USA 90: 2769-2773
58. Lipton SA, Sucher NJ, Kaiser PK and Dreyer EB (1991) Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 7: 111-118
59. Brew BJ, Corbeil J, Pemberton L, Evans L, Saito K, Penny R, Cooper DA and Heyes MP (1995) Quinolinic acid production is related to macrophage tropic isolates of HIV-1. J. Neurovirol. 1: 369-374
60. Yeh MW, Kaul M, Zheng J, Nottet HS, Thylin M, Gendelman HE and Lipton SA (2000) Cytokine-stimulated, but not HIV-infected, human monocytederived macrophages produce neurotoxic levels of L-cysteine. J. Immunol. 164: 4265-4270
61. Zhao J, Lopez AL, Erichsen D, Herek S, Cotter RL, Curthoys NP and Zheng J (2004) Mitochondrial glutaminase enhances extracellular glutamate production in HIV-1-infected macrophages: linkage to HIV-1 associated dementia. J. Neurochem. 88: 169-180
62. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P and Lipton SA (1995) Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA 92: 7162-7166
63. Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW and Miller RJ (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. USA 95: 14500-14505
64. Liu Y, Jones M, Hingtgen CM, Bu G, Laribee N, Tanzi RE, Moir RD, Nath A and He JJ (2000) Uptake of HIV-1 Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat. Med. 6: 1380-1387
65. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana- Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M and Moser B (1996) The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382: 833-835
66. Tran PB and Miller RJ (2003) Chemokine receptors: signposts to brain development and disease. Nat. Rev. Neurosci. 4: 444-455
67. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT and Springer TA (1998) Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. USA 95: 9448-9453
68. Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N, Nishikawa S, Kishimoto T and Nagasawa T (1998) The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393: 591-594
69. Zou YR, Kottmann AH, Kuroda M, Taniuchi I and Littman DR (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393: 595-599
70. Locati M and Murphy PM (1999) Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. Annu. Rev. Med. 50: 425-440
71. Lapidot T and Petit I (2002) Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp. Hematol. 30: 973-981
72. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM and Berger EA (1996) CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-1958
73. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J and Springer TA (1996) The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382: 829-833
74. He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hofmann W, Newman W, Mackay CR, Sodroski J and Gabuzda D (1997) CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385: 645-649
75. Michael NL and Moore JP (1999) HIV-1 entry inhibitors: evading the issue [news] [see comments]. Nat. Med. 5: 740-742
76. Ohagen A, Ghosh S, He J, Huang K, Chen Y, Yuan M, Osathanondh R, Gartner S, Shi B, Shaw G and Gabuzda D (1999) Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope. J. Virol. 73: 897-906
77. Chen W, Sulcove J, Frank I, Jaffer S, Ozdener H and Kolson DL (2002) Development of a human neuronal cell model for human immunodeficiency virus (HIV)-infected macrophage-induced neurotoxicity: apoptosis induced by HIV type 1 primary isolates and evidence for involvement of the Bcl-2/Bcl-xLsensitive intrinsic apoptosis pathway. J. Virol. 76: 9407-9419
78. Rottman JB, Ganley KP, Williams K, Wu L, Mackay CR and Ringler DJ (1997) Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am. J. Pathol. 151: 1341-1351
79. Zhang L, He T, Talal A, Wang G, Frankel SS and Ho DD (1998) In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J. Virol. 72: 5035-5045
80. Hesselgesser J, Taub D, Baskar P, Greenberg M, Hoxie J, Kolson DL and Horuk R (1998) Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr. Biol. 8: 595-598
81. Kaul M and Lipton SA (1999) Chemokines and activated macrophages in gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA 96: 8212-8216
82. Garden GA, Guo W, Jayadev S, Tun C, Balcaitis S, Choi J, Montine TJ, Moller T and Morrison RS (2004) HIV associated neurodegeneration requires p53 in neurons and microglia. FASEB J. 18: 1141-1143
83. Zheng J, Thylin MR, Ghorpade A, Xiong H, Persidsky Y, Cotter R, Niemann D, Che M, Zeng YC, Gelbard HA, Shepard RB, Swartz JM and Gendelman HE (1999) Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J. Neuroimmunol. 98: 185-200
84. Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, Vescovi A, Bagetta G, Kollias G, Meldolesi J and Volterra A (2001) CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4: 702-710
85. Kaul M (2002) Chemokines and their receptors in HIV-associated dementia. J. Neurovirol. 8 (Suppl. 1): 41-42
86. McGrath KE, Koniski AD, Maltby KM, McGann JK and Palis J (1999) Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Dev. Biol. 213: 442-456
87. Gleichmann M, Gillen C, Czardybon M, Bosse F, Greiner-Petter R, Auer J and Muller HW (2000) Cloning and characterization of SDF-1gamma, a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system. Eur. J. Neurosci. 12: 1857-1866
88. Stumm RK, Rummel J, Junker V, Culmsee C, Pfeiffer M, Krieglstein J, Hollt V and Schulz S (2002) A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J. Neurosci. 22: 5865-5878
89. Langford D, Sanders VJ, Mallory M, Kaul M and Masliah E (2002) Expression of stromal cell-derived factor 1alpha protein in HIV encephalitis. J. Neuroimmunol. 127: 115-126
90. Zhang K, McQuibban GA, Silva C, Butler GS, Johnston JB, Holden J, Clark- Lewis I, Overall CM and Power C (2003) HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat. Neurosci. 6: 1064-1071
91. Johnston JB, Jiang Y, van Marle G, Mayne MB, Ni W, Holden J, McArthur JC and Power C (2000) Lentivirus infection in the brain induces matrix metalloproteinase expression: role of envelope diversity. J. Virol. 74: 7211-7220
92. Sanders VJ, Pittman CA, White MG, Wang G, Wiley CA and Achim CL (1998) Chemokines and receptors in HIV encephalitis. AIDS 12: 1021-1026
93. McManus CM, Weidenheim K, Woodman SE, Nunez J, Hesselgesser J, Nath A and Berman JW (2000) Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. Am. J. Pathol. 156: 1441-1453
94. Peng H, Huang Y, Rose J, Erichsen D, Herek S, Fujii N, Tamamura H and Zheng J (2004) Stromal cell-derived factor 1-mediated CXCR4 signaling in rat and human cortical neural progenitor cells. J. Neurosci. Res. 76: 35-50
95. Horner PJ and Gage FH (2000) Regenerating the damaged central nervous system. Nature 407: 963-970
96. van Praag H, Schinder AF, Christie BR, Toni N, Palmer TD and Gage FH (2002) Functional neurogenesis in the adult hippocampus. Nature 415: 1030-1034
97. Robinson AP, White TM and Mason DW (1986) Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunology 57: 239-247
98. Kokaia Z and Lindvall O (2003) Neurogenesis after ischaemic brain insults. Curr. Opin. Neurobiol. 13: 127-132
99. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C and Hen R (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809
100. Zlotnik A, Morales J and Hedrick JA (1999) Recent advances in chemokines and chemokine receptors. Crit. Rev. Immunol. 19: 1-47
101. Jazin EE, Soderstrom S, Ebendal T and Larhammar D (1997) Embryonic expression of the mRNA for the rat homologue of the fusin/CXCR-4 HIV-1 coreceptor. J. Neuroimmunol. 79: 148-154
102. Lu M, Grove EA and Miller RJ (2002) Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc. Natl. Acad. Sci. USA 99: 7090-7095
103. Stumm RK, Zhou C, Ara T, Lazarini F, Dubois-Dalcq M, Nagasawa T, Hollt V and Schulz S (2003) CXCR4 regulates interneuron migration in the developing neocortex. J. Neurosci. 23: 5123-5130
104. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP and Gurtner GC (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10: 858-864
105. val of human neural progenitor cells. Stem. Cells 22: 109-118 106. Krathwohl MD and Kaiser JL (2004) HIV-1 promotes quiescence in human neural progenitor cells. J. Infect. Dis. 190: 216-226
106. Zheng J, Thylin MR, Persidsky Y, Williams CE, Cotter RL, Zink W, Ryan L, Ghorpade A, Lewis K and Gendelman HE (2001) HIV-1 infected immune competent mononuclear phagocytes influence the pathways to neuronal demise. Neurotox. Res. 3: 461-484
107. Hesselgesser J, Halks-Miller M, DelVecchio V, Peiper SC, Hoxie J, Kolson DL, Taub D and Horuk R (1997) CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons. Curr. Biol. 7: 112-121
108. Meucci O, Fatatis A, Simen AA and Miller RJ (2000) Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl. Acad. Sci. USA 97: 8075-8080
109. Fontana G, Valenti L and Raiteri M (1997) gp120 can revert antagonism at the glycine site of NMDA receptors mediating GABA release from cultured hippocampal neurons. J. Neurosci. Res. 49: 732-738
110. Nath A, Haughey NJ, Jones M, Anderson C, Bell JE and Geiger JD (2000) Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann. Neurol. 47: 186-194
111. Piller SC, Jans P, Gage PW and Jans DA (1998) Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathology. Proc. Natl. Acad. Sci. USA 95: 4595-4600
112. Shi B, De Girolami U, He J, Wang S, Lorenzo A, Busciglio J and Gabuzda D (1996) Apoptosis induced by HIV-1 infection of the central nervous system. J. Clin. Invest. 98: 1979-1990
113. Xiong H, Zeng YC, Lewis T, Zheng J, Persidsky Y and Gendelman HE (2000) HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia. J. Neurovirol. 6: S14-S23
114. Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, Ruff MR and Pert CB (1988) Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335: 639-642
115. Kaiser PK, Offermann JT and Lipton SA (1990) Neuronal injury due to HIV-1 envelope protein is blocked by anti-gp120 antibodies but not by anti-CD4 antibodies. Neurology 40: 1757-1761
116. Dreyer EB, Kaiser PK, Offermann JT and Lipton SA (1990) HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248: 364-367
117. Pulliam L, Herndier BG, Tang NM and McGrath MS (1991) Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J. Clin. Invest. 87: 503-512
118. Lipton SA (1993) Prospects for clinically tolerated NMDA antagonists: openchannel blockers and alternative redox states of nitric oxide. Trends Neurosci. 16: 527-532
119. Gendelman HE, Genis P, Jett M, Zhai QH and Nottet HS (1994) An experimental model system for HIV-1-induced brain injury. Adv. Neuroimmunol. 4: 189-193
120. Toggas SM, Masliah E and Mucke L (1996) Prevention of HIV-1 gp120- induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res. 706: 303-307
121. Tenneti L, D’Emilia DM, Troy CM and Lipton SA (1998) Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J. Neurochem. 71: 946-959
122. Budd SL, Tenneti L, Lishnak T and Lipton SA (2000) Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc. Natl. Acad. Sci. USA 97: 6161-6166
123. Ghatan S, Larner S, Kinoshita Y, Hetman M, Patel L, Xia Z, Youle RJ and Morrison RS (2000) p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J. Cell. Biol. 150: 335-347
124. Garden GA, Budd SL, Tsai E, Hanson L, Kaul M, D’Emilia DM, Friedlander RM, Yuan J, Masliah E and Lipton SA (2002) Caspase cascades in human immunodeficiency virus-associated neurodegeneration. J. Neurosci. 22: 4015-4024
125. Sattler R, Xiong Z, Lu WY, Hafner M, MacDonald JF and Tymianski M (1999) Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 284: 1845-1848
126. Nicotera P, Ankarcrona M, Bonfoco E, Orrenius S and Lipton SA (1997) Neuronal necrosis and apoptosis: two distinct events induced by exposure to glutamate or oxidative stress. Adv. Neurol. 72: 95-101
127. Gonzalez-Zulueta M, Feldman AB, Klesse LJ, Kalb RG, Dillman JF, Parada LF, Dawson TM and Dawson VL (2000) Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc. Natl. Acad. Sci. USA 97: 436-441
128. Tenneti L, D’Emilia DM and Lipton SA (1997) Suppression of neuronal apoptosis by S-nitrosylation of caspases. Neurosci. Lett. 236: 139-142
129. Haughey NJ, Cutler RG, Tamara A, McArthur JC, Vargas DL, Pardo CA, Turchan J, Nath A and Mattson MP (2004) Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia. Ann. Neurol. 55: 257-267
130. Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, Smith JW, Liddington RC and Lipton SA (2002) S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297: 1186-1190
131. Persidsky Y, Buttini M, Limoges J, Bock P and Gendelman HE (1997) An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis. J. Neurovirol. 3: 401-416
132. Pulliam L, Zhou M, Stubblebine M and Bitler CM (1998) Differential modulation of cell death proteins in human brain cells by tumor necrosis factor alpha and platelet activating factor. J. Neurosci. Res. 54: 530-538
133. Talley AK, Dewhurst S, Perry SW, Dollard SC, Gummuluru S, Fine SM, New D, Epstein LG, Gendelman HE and Gelbard HA (1995) Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes Bcl-2 and crma. Mol. Cell Biol. 15: 2359-2366
134. Shi B, Raina J, Lorenzo A, Busciglio J and Gabuzda D (1998) Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J. Neurovirol. 4: 281-290
135. Ryan LA, Peng H, Erichsen DA, Huang Y, Persidsky Y, Zhou Y, Gendelman HE and Zheng J (2004) Links between TNF-related apoptosis-inducing ligand mediated human neuronal apoptosis and HIV-1-associated dementia. J. Neuroimmunol. 148: 127-139
136. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR and Mucke L (1994) Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367: 188-193
137. Marshall DC, Wyss-Coray T and Abraham CR (1998) Induction of matrix metalloproteinase-2 in human immunodeficiency virus-1 glycoprotein 120 transgenic mouse brains. Neurosci. Lett. 254: 97-100
138. D’hooge R, Franck F, Mucke L and De Deyn PP (1999) Age-related behavioural deficits in transgenic mice expressing the HIV-1 coat protein gp120. Eur. J. Neurosci. 11: 4398-4402
139. Anderson ER, Gendelman HE and Xiong H (2004) Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis. J. Neurosci. 24: 7194-7198
140. Milligan CE, Cunningham TJ and Levitt P (1991) Differential immunochemical markers reveal the normal distribution of brain macrophages and microglia in the developing rat brain. J. Comp. Neurol. 314: 125-135
141. Luo X, Carlson KA, Wojna V, Mayo R, Biskup TM, Stoner J, Anderson J, Gendelman HE and Melendez LM (2003) Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment. Neurology 60: 1931-1937
142. Elkabes S, DiCicco-Bloom EM and Black IB (1996) Brain microglia/ macrophages express neurotrophins that selectively regulate microglial proliferation and function. J. Neurosci. 16: 2508-2521
143. Lazarov-Spiegler O, Solomon AS, Zeev-Brann AB, Hirschberg DL, Lavie V and Schwartz M (1996) Transplantation of activated macrophages overcomes central nervous system regrowth failure. FASEB J. 10: 1296-1302
144. Rapalino O, Lazarov-Spiegler O, Agranov E, Velan GJ, Yoles E, Fraidakis M, Solomon A, Gepstein R, Katz A, Belkin M, Hadani M and Schwartz M (1998) Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat. Med. 4: 814-821
145. Gras G, Chretien F, Vallat-Decouvelaere AV, Le Pavec G, Porcheray F, Bossuet C, Leone C, Mialocq P, Dereuddre-Bosquet N, Clayette P, Le Grand R, Creminon C, Dormont D, Rimaniol AC and Gray F (2003) Regulated expression of sodium-dependent glutamate transporters and synthetase: a neuroprotective role for activated microglia and macrophages in HIV infection? Brain Pathol. 13: 211-222
146. Miwa T, Furukawa S, Nakajima K, Furukawa Y and Kohsaka S (1997) Lipopolysaccharide enhances synthesis of brain-derived neurotrophic factor in cultured rat microglia. J. Neurosci. Res. 50: 1023-1029
147. Nicholas RS, Stevens S, Wing MG and Compston DA (2002) Microgliaderived IGF-2 prevents TNFalpha induced death of mature oligodendrocytes in vitro. J. Neuroimmunol. 124: 36-44
148. Garaci E, Caroleo MC, Aloe L, Aquaro S, Piacentini M, Costa N, Amendola A, Micera A, Calio R, Perno CF and Levi-Montalcini R (1999) Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV. Proc. Natl. Acad. Sci. USA 96: 14013-14018
149. Chao CC, Hu S, Sheng WS and Peterson PK (1995) Tumor necrosis factoralpha production by human fetal microglial cells: regulation by other cytokines. Dev. Neurosci. 17: 97-105
150. Kullander K, Kylberg A and Ebendal T (1997) Specificity of neurotrophin-3 determined by loss-of-function mutagenesis. J. Neurosci. Res. 50: 496-503
151. Batchelor PE, Liberatore GT, Wong JY, Porritt MJ, Frerichs F, Donnan GA and Howells DW (1999) Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci. 19: 1708-1716
152. Meucci O and Miller RJ (1996) Gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-beta1. J. Neurosci. 16: 4080-4088
153. Tornatore C, Chandra R, Berger JR and Major EO (1994) HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44 (Part 1): 481-487
154. Gendelman HE, Persidsky Y, Ghorpade A, Limoges J, Stins M, Fiala M and Morrisett R (1997) The neuropathogenesis of the AIDS dementia complex. AIDS 11 (Suppl. A): S35-S45
155. Nath A (1999) Pathobiology of human immunodeficiency virus dementia. Semin. Neurol. 19: 113-127
156. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, Dawson TM and Dawson VL (1996) Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274: 1917-1921
157. Nath A, Psooy K, Martin C, Knudsen B, Magnuson DS, Haughey N and Geiger JD (1996) Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J. Virol. 70: 1475-1480
158. Gelbard HA, Nottet HS, Swindells S, Jett M, Dzenko KA, Genis P, White R, Wang L, Choi YB, Zhang D, Lipton SA, Tourtellotte WW, Epstein LG and Gendelman HE (1994) Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J. Virol. 68: 4628-4635
159. Nottet HS, Jett M, Flanagan CR, Zhai QH, Persidsky Y, Rizzino A, Bernton EW, Genis P, Baldwin T, Schwartz J, LaBenz CJ and Gendelman HE (1995) A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J. Immunol. 154: 3567-3581
160. Gelbard HA, Dzenko KA, DiLoreto D, del Cerro C, del Cerro M and Epstein LG (1993) Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev. Neurosci. 15: 417-422
161. Kerr SJ, Armati PJ, Pemberton LA, Smythe G, Tattam B and Brew BJ (1997) Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages. Neurology 49: 1671-1681
162. Fischer-Smith T, Croul S, Sverstiuk AE, Capini C, L’Heureux D, Regulier EG, Richardson MW, Amini S, Morgello S, Khalili K and Rappaport J (2001) CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J. Neurovirol. 7: 528-541
163. Miura Y, Misawa N, Kawano Y, Okada H, Inagaki Y, Yamamoto N, Ito M, Yagita H, Okumura K, Mizusawa H and Koyanagi Y (2003) Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection. Proc. Natl. Acad. Sci. USA 100: 2777-2782
164. Nitsch R, Bechmann I, Deisz RA, Haas D, Lehmann TN, Wendling U and Zipp F (2000) Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL). Lancet. 356: 827-828
165. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C and Smith CA (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682
166. Pan G, O’Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J and Dixit VM (1997) The receptor for the cytotoxic ligand TRAIL. Science 276: 111-113
167. Degli-Esposti MA, Smolak PJ, Walczak H, Waugh J, Huang CP, DuBose RF, Goodwin RG and Smith CA (1997) Cloning and characterization of TRAIL-R3, a novelmember of the emerging TRAIL receptor family. J. Exp.Med. 186: 1165-1170
168. Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, Silverman C, Dul E, Appelbaum ER, Eichman C, DiPrinzio R, Dodds RA, James IE, Rosenberg M, Lee JC and Young PR (1998) Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J. Biol. Chem. 273: 14363-14367
169. Deng Y, Lin Y and Wu X (2002) TRAIL-induced apoptosis requires Baxdependent mitochondrial release of Smac/DIABLO. Genes Dev. 16: 33-45
170. Green DR (2003) The suicide in the thymus, a twisted trail. Nat. Immunol. 4: 207-208
171. Huang DC and Strasser A (2000) BH3-only proteins - essential initiators of apoptotic cell death. Cell 103: 839-842
172. Boatright KM, Renatus M, Scott FL, Sperandio S, Shin H, Pedersen IM, Ricci JE, Edris WA, Sutherlin DP, Green DR and Salvesen GS (2003) A unified model for apical caspase activation. Mol. Cell. 11: 529-541
173. Ashkenazi A and Dixit VM (1998) Death receptors: signaling and modulation. Science 281: 1305-1308
174. Goyal L (2001) Cell death inhibition: keeping caspases in check. Cell 104: 805-808
175. Melton ST, Kirkwood CK and Ghaemi SN (1997) Pharmacotherapy of HIV dementia. Ann. Pharmacother. 31: 457-473
176. Clifford DB (1999) Central neurologic complications of HIV infection. Curr. Infect. Dis. Rep. 1: 187-191
177. Lipton SA (1992) Memantine prevents HIV coat protein-induced neuronal injury in vitro. Neurology 42: 1403-1405
178. Schifitto G, Sacktor N, Marder K, McDermott MP, McArthur JC, Kieburtz K, Small S and Epstein LG (1999) Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment* Neurological AIDS Research Consortium. Neurology 53: 391-396
179. Navia BA, Dafni U, Simpson D, Tucker T, Singer E, McArthur JC, Yiannoutsos C, Zaborski L and Lipton SA (1998) A phase I/II trial of nimodipine for HIVrelated neurologic complications. Neurology 51: 221-228
180. Sacktor N, Schifitto G, McDermott MP, Marder K, McArthur JC and Kieburtz K (2000) Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study. Neurology 54: 233-235
181. Chen S and Hillman DE (1994) Immunohistochemical localization of protein kinase C delta during postnatal development of the cerebellum. Brain Res. Dev. Brain Res. 80: 19-25
182. Manji HK, McNamara R, Chen G and Lenox RH (1999) Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic- depressive illness. Aust. N Z J. Psychiatry 33 (Supp l.): S65-S83
183. Lenox RH, McNamara RK, Watterson JM and Watson DG (1996) Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain? J. Clin. Psychiatry 57 (Suppl 13): 23-31 discussion 32-33
184. Dou H, Birusingh K, Faraci J, Gorantla S, Poluektova LY, Maggirwar SB, Dewhurst S, Gelbard HA and Gendelman HE (2003) Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis. J. Neurosci. 23: 9162-9170
185. Kim HS, Kim EM, Lee JP, Park CH, Kim S, Seo JH, Chang KA, Yu E, Jeong SJ, Chong YH and Suh YH (2003) C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression. FASEB J. 17: 1951-1953
186. Hong M and Lee VM (1997) Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J. Biol. Chem. 272: 19547-19553
187. Digicaylioglu M, Kaul M, Dowen R, Fletcher L and Lipton SA (2003) Combined neuroprotective effects of EPO IGF-I from Tau hyperphosphorylation HIV/ gp120-induced neuronal apoptosisAbstract Viewer/Itinerary Planner (Washington DC: Society for Neuroscience). Online Program No. 216.18
188. Everall IP, Bell C, Mallory M, Langford D, Adame A, Rockestein E and Masliah E (2002) Lithium ameliorates HIV-gp120-mediated neurotoxicity. Mol. Cell Neurosci. 21: 493-501
189. Digicaylioglu M, Kaul M, Fletcher L, Dowen R and Lipton SA (2004) Erythropoietin protects cerebrocortical neurons from HIV-1/gp120-induced damage. Neuroreport 15: 761-763
190. Lipton SA (2004) Erythropoietin for neurologic protection and diabetic neuropathy. N. Engl. J. Med. 350: 2516-2517
191. Digicaylioglu M, Garden G, Timberlake S, Fletcher L and Lipton SA (2004) Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 101: 9855-9860
192. Wells TNC, Proudfoot AEI, Power CA, Lusti-Narasimhan M, Alouani S, Hoogewerf AJ and Peitsch MC (1996) The molecular basis of the chemokine/ chemokine receptor interaction - scope for design of chemokine antagonists. Methods 10: 126-134
193. Bruno V, Copani A, Besong G, Scoto G and Nicoletti F (2000) Neuroprotective activity of chemokines against N-methyl-D-aspartate or beta-amyloid-induced toxicity in culture. Eur. J. Pharmacol. 399: 117-121
194. Letendre SL, Lanier ER and McCutchan JA (1999) Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1. J. Infect. Dis. 180: 310-319
195. Yuan J and Yankner BA (2000) Apoptosis in the nervous system. Nature 407: 802-809
196. Kikuchi M, Tenneti L and Lipton SA (2000) Role of p38 mitogen-activated protein kinase in axotomy-induced apoptosis of rat retinal ganglion cells. J. Neurosci. 20: 5037-5044
197. Chapman GA, Moores K, Harrison D, Campbell CA, Stewart BR and Strijbos PJ (2000) Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J. Neurosci. (Online) 20: RC87
198. Kaul M and Lipton SA (2002) AIDS In: Ionotropic Glutamate Receptors as Therapeutic Targets, Lodge D, Danysz W, Parsons CG, eds (Mountain Home, TN: FP Graham Publishing Co). 509-538